United Kingdom · Series A startup

Who invested in Verdiva Bio

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$601Mraised across 3 rounds since 2025, from 3 sources

$411MSeries A$69MRound$121MRound
Latest round
Round, $121MMay 2026
Biggest round
$411MSeries A · Jan 2025
Step-upi
1.8×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026
$411MSeries A$69MRound$121MRound
First round
Series A, $411M
Jan 2025
Biggest round
$411M
Series A · Jan 2025
Usual gap between rounds
13 months
the median of 2

The rounds

  1. May 2026
    Round$121M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  2. Jan 2026
    Round$69M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  3. Jan 2025

Funding filed with regulators

Verdiva Bio filed 3 raises, $372M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. May 2026$121MUK share allotment
  2. Jan 2026$69MUK share allotment
  3. Oct 2024$182MUK share allotment

Founders and team

From Verdiva Bio's own website: 7 on the team.

  • Khurem FarooqChief Executive Officer
  • Ashley TaylorChief Technology Officer
  • Jane HughesChief Scientific Officer
  • Tapan ManiarChief Business Officer
  • Weidong ZhongChief Strategy Officer
  • Andrew ProsserSVP, Head of Finance
  • Elaine JohnstonGeneral Counsel

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

OrbiMedPrivate equity1round
RA Capital ManagementPrivate equity1round
General AtlanticPrivate equity1round
Forbion Capital PartnersPrivate equity1round
Lilly Asia VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Verdiva Bio

Who invested in Verdiva Bio?

Verdiva Bio's investors include OrbiMed, RA Capital Management, General Atlantic, Forbion Capital Partners and Lilly Asia Ventures.

How much has Verdiva Bio raised?

Verdiva Bio has raised $601M across 3 rounds since 2025.

When did Verdiva Bio last raise?

Verdiva Bio's most recent round, $121M, was in May 2026.

What was Verdiva Bio's biggest round?

Verdiva Bio's largest round on record is $411M (Series A), in Jan 2025.

Who backed Verdiva Bio first?

Verdiva Bio's first round on record, in Jan 2025, was backed by OrbiMed, RA Capital Management and General Atlantic and 2 others.

What stage is Verdiva Bio at?

Verdiva Bio's latest named round is a Series A, in Jan 2025.

Where is Verdiva Bio based?

Verdiva Bio is based in the United Kingdom.

Companies like Verdiva Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.